CCM
CELG

Catawba Capital Management’s Celgene Corp CELG Stock Holding History

Catawba Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,320
Closed -$338K – 230
2017
Q3 		$338K Sell
2,320
-105
-4% -$14.3K 0.08% 173
2017
Q2 		$315K Hold
2,425
– – 0.07% 177
2017
Q1 		$302K Buy
2,425
+260
+12% +$31.1K 0.07% 202
2016
Q4 		$251K Buy
+2,165
New +$241K 0.06% 217
2014
Q1 		– Sell
-7,520
Closed -$635K – 256
2013
Q4 		$635K Buy
7,520
+100
+1% +$7.91K 0.15% 133
2013
Q3 		$572K Hold
7,420
– – 0.15% 138
2013
Q2 		$434K Buy
+7,420
New +$447K 0.12% 152

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Catawba Capital Management's CELG Position: Q4 2017 in Review

Catawba Capital Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 2,320 shares — an estimated $338K sold.

Catawba Capital Management first reported a position in CELG in Q2 2013 and held it in 7 quarters. The position peaked at $635K in Q4 2013. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Catawba Capital Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Catawba Capital Management sold 2,320 Celgene Corp shares in Q4 2017, an estimated $338K.
  • Catawba Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 7 quarters.
  • Catawba Capital Management's Celgene Corp position peaked at $635K in Q4 2013.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Catawba Capital Management's 13F filing for Q4 2017, filed 19 Jan 2018.